Marinus Pharmaceuticals options imply 12.7% move in share price post-earnings

Pre-earnings options volume in Marinus Pharmaceuticals is normal with calls leading puts :. Implied volatility suggests the market is anticipating a move near 12.7%, or 0c, after results are released. Median move over the past eight quarters is 9.2%.